This volume concentrates on understanding pathophysiology, discussing differentials, and discussing new developments. While maintaining fundamental topics in Nephrology, focus is given on areas of nephrology that are expected to grow over the next ten years, such as genetics, obesity, complement-mediated diseases, and interventional Nephrology. The clinical scenarios discussed are distributed across 34 independent chapters relating to general nephrology, extracorporeal therapies, kidney transplantation, glomerular and tubulointerstitial disorders. The lead contributors are Professors or former Professors from major educational institutions in India, senior faculty members from private teaching institutions, with experienced assistant professorsas co-authors. As in the previous edition, there are more than 50 contributors who have generously shared their experience and expertise. For this edition, the case scenarios discussed by eminent scientists and clinicians from the US will give an alternative viewpoint to approaching clinical problems. Following each case study and discussion, there are multiple-choice questions with their responses, and important references or recommendations for more reading.
Grand Rounds in Nephrology Vol. 2
₹2,595.00
| Weight | 900 kg |
|---|---|
| Dimensions | 23 × 15.5 × 2.3 cm |
Customer Reviews
There are no reviews yet.
Related products
-
Current Progress In Nephrology Volume 3
₹1,995.00In the third volume of Current Progress in Nephrology, recent advances in different areas of kidney disease have been authored by eminent clinicians. The first few chapters discuss the genetics of renal development, regenerative medicine in relation to kidney, molecular diagnostics. Newer diagnostic modalities like functional magnetic resonance imaging, point of care ultrasonography and electron microscopy of organised deposits in kidney diseases are discussed in the subsequent 3 chapters. Diagnosing and managing difficult conditions of chronic kidney disease like, hepatorenal syndrome, pregnancy related renal problems, and scleroderma crisis are discussed in appropriate chapters. Anaemia, usually associated with CKD, is a significant cause of left ventricular hypertrophy and cardiovascular disease. The guidelines for correcting anaemia with iron supplementation and erythropoietin stimulating agents are provided in an appropriate chapter. Autosomal dominant rubulointerstitial kidney disease, a frequent cause of progressive CKD often remains an underdiagnosed condition and has been highlighted in one nice review. Understanding another a rare condition, thrombotic miocroangiopathy is important since it may lead to endstage renal disease or death, if not identified and appropriately treated in time.
-
Current Progress in Obstetrics and Gynecology – Volume 5
₹1,225.00In its 5th Volume the now CLASSIC comes with a value addition in the form of Multiple Choice Questions, which would highly beneficial to one and all. The Editors have gathered an ensemble of acclaimed clinicians giving an insight to various key aspect in Obstetrics and Gynaecology.
-
Current Progress in Nephrology Volume 2
₹1,500.00The aim of the 2nd volume of this book is to address the basic concepts and newer developments in selected areas of clinical nephrology, dialysis and renal transplantation. Selected topics on interest with reference to recent developments, updated classifications or advances in pathogenesis and treatment. Nephrologists from around the world have contributed to this one of its kind book.
-
Current Progress in Orthopedics Volume 1
₹1,500.00The book disseminates orthopedic knowledge and shares the experience and skill of the best orthopedic surgeons from around the world. The aim of the book with almost 60 contributing authors which covers the subjects from Pediatric Orthopedics to Arthroplasty for the Aging Population and from Cartilage Repair to Open Fracture and Spine Surgery.
-
COVID – 19 VACCINES A Comprehensive Overview
₹1,595.00We are amid a pandemic that continues to smoulder almost everywhere with raging fire off and on at different places. It has not only devastated hundreds of thousands of families who lost someone to the virus and affected over 300 million people directly, it has affected all 7.9 billion of us in some way or other. At the same time, humanity has risen well to the pandemic challenges. It was realized very early during the current outbreal that safe and effcacious vaccines would be crucial in tackling the pandemic. The unprecedented global collaboration among all stakeholders: Scientists, pharmaceutical industry, funding agencies and Governments demonstrated what a global will could do: hundreds of vaccine candidates developed, and vaccine deployment started within 12 months of isolation of new virus something that takes over a decade otherwise.
Be the first to review “Grand Rounds in Nephrology Vol. 2”